STOCK TITAN

CollPlant Biotechnologies Ltd. - $CLGN STOCK NEWS

Welcome to our dedicated page for CollPlant Biotechnologies Ltd. news (Ticker: $CLGN), a resource for investors and traders seeking the latest updates and insights on CollPlant Biotechnologies Ltd. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CollPlant Biotechnologies Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CollPlant Biotechnologies Ltd.'s position in the market.

News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.16%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.46%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.29%
Tags
none
-
CollPlant Biotechnologies Ltd.

Nasdaq:CLGN

CLGN Rankings

CLGN Stock Data

64.91M
7.82M
10.16%
12.23%
0.09%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United States of America
P O Box 4132

About CLGN

collplant is a regenerative medicine company focused on 3d bioprinting of tissues and organs, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. our products are based on our rhcollagen (recombinant human collagen) that is produced with collplant’s proprietary plant based genetic engineering technology. our products address indications for diverse fields of organ and tissue repair, and are ushering in a new era in regenerative medicine. our flagship rhcollagen bioink product line is ideal for 3d bioprinting of tissues and organs, and our unique vergenix line of rhcollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. collplant is a public company listed on the tel aviv stock exchange and on nasdaq (clgn).